Lab-Grown cells offer hope for transplant complication
NCT ID NCT06321198
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new treatment made from special stem cells (iMSC) for people with a serious complication after bone marrow transplant called graft-versus-host disease that does not respond to steroids. The treatment aims to control the disease by calming the immune system. About 12 participants aged 4 to 70 will receive the cells to see if it is safe and helps improve their condition.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STEROID-REFRACTORY ACUTE GRAFT-VERSUS-HOST DISEASE(SR-AGVHD) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Anhui Provincial Hospital
RECRUITINGHefei, Anhui, 230036, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.